Influence of electronic cigarette liquid flavors and nicotine concentration on subjective measures of abuse liability in young adult cigarette smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Cobb (2019)
Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
Individual Clinical
Pharmacokinetics & Abuse Liability; Safety
Adverse Effects
Cobb (2021)
Changes in Biomarkers of Cigarette Smoke Exposure after 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: a Randomized Controlled Confinement Study in adult Smokers.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Cohen (2021)
assessing the association Between Electronic Cigarette Use among Cannabis-Naive adolescents and Future Cannabis Use-Overlapping Substances.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Compton (2022)
how Irritating! Electronic Cigarettes Not “95% Safer” Than Combustible Cigarettes: Recent Mechanistic Insights Into Endothelial Dysfunction.
Individual Clinical
Safety
Adverse Effects
Conklin (2022)
Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study.
Individual Clinical
Safety
Adverse Effects
Cook (2023)
Characterizing ENDS use in young adults with ecological momentary assessment: Results from a pilot study.
Individual Clinical
Consumer Use
Youth Use & Appeal
Cooper (2019)
Gene Expression alterations in the Bronchial Epithelium of e-Cigarette Users.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Corbett (2019)
Vascular effects of a single bout of electronic cigarette use.
Individual Clinical
Safety
Adverse Effects
Cossio (2020)
Patterns of sustained e-cigarette use in a sample of young adults.
Individual Clinical
Consumer Use
Youth Use & Appeal
Creamer (2019)